Joseph Renzulli

Dr. Joseph Renzulli is an Associate Professor of Urology at Yale School of Medicine and serves as Chief of Urology at Lawrence + Memorial Hospital and Westerly Hospital. His clinical focus includes minimally invasive and robotic-assisted surgeries for urologic cancers, particularly prostate cancer. He leads multiple prostate cancer clinical trials, emphasizing cutting-edge treatments and patient-centered care.

Education & Training:

• Bachelor of Arts (Biology), Boston University, 1997
• Medical Doctorate, Boston University School of Medicine, 2001
• Residency in Urology, Yale School of Medicine, 2006

Research Interests: Dr. Renzulli's research centers on prostate cancer diagnosis and treatment, including comparative effectiveness of biopsy techniques (e.g., micro-ultrasound vs MRI fusion biopsy) and clinical trials evaluating therapies like enzalutamide. He investigates sociodemographic factors influencing cancer outcomes and innovations in surgical practices to reduce complications.

Recent Research Trends: His work emphasizes improving diagnostic accuracy, optimizing patient selection for treatments, and advancing minimally invasive approaches. Collaborations focus on image-guided interventions and novel drug therapies in active surveillance.

Awards & Grants: While specific awards are not listed, his leadership in high-impact clinical trials (e.g., OPTIMUM) reflects recognized expertise. Grants likely support his trial-driven research.

Teaching & Mentorship: As a Yale faculty member, he contributes to training residents and fellows in advanced urologic surgery and oncology. His mentorship extends to clinical research and surgical innovation.

Labs & Teams: Collaborates with the Prostate & Urologic Cancers Program and Yale Cancer Center. Active in multidisciplinary teams advancing prostate cancer care through translational research and clinical trials.